Ensign Peak Advisors, Inc Atea Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$3.21 - $5.06 $49,915 - $78,683
15,550 Added 22.71%
84,030 $314,000
Q1 2023

May 15, 2023
BUY
$3.0 - $4.97 $58,500 - $96,915
19,500 Added 39.81%
68,480 $229,000
Q4 2022

Feb 13, 2023
BUY
$4.35 - $6.17 $83,520 - $118,464
19,200 Added 64.47%
48,980 $235,000
Q4 2021

Feb 11, 2022
BUY
$7.67 - $44.59 $228,412 - $1.33 Million
29,780 New
29,780 $266,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $272M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email